Alpha PH expects to sell more than 20,000 units of new rapid test before Easter
Northern Ireland company, Alpha PH, has just launched a Saliva Rapid Test for Covid-19 that gives test results within 15 minutes, the first test of its kind to be released in Northern Ireland. The new test offers a rapid, easy to use and affordable testing solution and the company expects to fulfil more than 20,000 orders before Easter, based on current demand for rapid Covid-19 testing solutions.
The IRIS SARS-CoV-2 Ag Saliva Rapid Test is designed to deliver accurate, reliable test results within 15 minutes, based on the provision of a small saliva sample. From the saliva sample, the IRIS Saliva Rapid Test can detect the virus that causes Covid-19, and is clinically more accurate at detecting the virus than a nasal swab test, offering a 99.5% rate of clinical accuracy.
Providing a unique and easy to use alternative to nasal swab testing, the Saliva Rapid Test for Covid-19 is user-friendly and can be self-administered. The nature of the test makes it ideal for on-the-spot testing and offers an affordable and scalable solution for mass testing.
Arguably the world’s easiest Covid-19 test to use, this very accurate, rapid, non-swab Saliva Rapid Test from Alpha PH is now available in NI, UK and Ireland.
Speaking about the new IRIS Saliva Rapid Test, Alpha PH Director, Kevin Sweeney, comments: “The Saliva Rapid Test from Alpha PH is a ground-breaking development in current Covid-19 testing in Northern Ireland. Offering a minimally invasive testing alternative to nasal swab tests, while delivering even more accurate results, the Saliva Rapid Test is easy to implement. An accurate, affordable, rapid testing solution, the Saliva Rapid Test will have a key role to play in the safe re-opening of our society and workplaces.
“As we move forward, continued Covid-19 testing will play a crucial role in detecting and containing the virus within society, limiting further spreading of the virus as the Covid-19 vaccination programme continues to roll out to the wider public. The IRIS Saliva Rapid Test can significantly help to prevent the spread of Covid-19 by quickly and accurately diagnosing both symptomatic and asymptomatic people within a 15-minute frame. With its ease of use, performance and price point, it’s a game-changer when it comes to Covid-19 testing, providing an ideal testing solution that can help to get the economy back to normal, by ensuring safety and peace of mind for individuals, customers and workforces across the country.”
The Saliva Rapid Test from Alpha PH is conducted without the need for laboratory analysis, returning results in just 15 minutes. Accuracy is paramount and the IRIS SARS-CoV-2 Ag Saliva Rapid Test has been proven to deliver 99.9% specificity and sensitivity of more than 98.26%, with 99.5% clinical accuracy in testing.
The IRIS SARS-CoV-2 Ag Saliva Rapid Test from Alpha PH is the latest rapid Covid-19 test to be made available from the company which previously launched the first rapid swab test kit for Covid-19 in NI in partnership with European bio-technology company, Alpha Pharma.
Since its launch in September 2020, 53,000 units of the rapid swab Covid-19 test have since been sold to companies, sporting organisations, healthcare facilities and individuals, with orders being received from across Northern Ireland, Ireland and further afield.
The IRIS SARS-CoV-2 Ag Saliva Rapid Test for Covid-19 is available now at https://alphatestkits.com/product/saliva-rapid-test-for-coronavirus/, along with the VivaDiag SARS-CoV-2Ag rapid test (swab test) for Covid-19 and the IRIS VivaDiag Covid-19 IgM IgG rapid test (antibody test) which delivers a qualitative determination of lgM and lgG COVID-19 antibodies, indicating that a person has previously had the coronavirus.
Alpha PH strongly advise that those who receive a positive test result from the Saliva Rapid Test for Covid-19 arrange a PCR test immediately and consult their GP, following government guidelines in relation to isolation.
Please visit https://alphatestkits.com/product/saliva-rapid-test-for-coronavirus/ for further information.
- The IRIS SARS-CoV-2 Ag Saliva Rapid Test shows a clinical sensitivity of 98.26%.
- The IRIS SARS-CoV-2 Ag Saliva Rapid Test shows a clinical specificity of >99.99%.
- The IRIS SARS-CoV-2 Ag Saliva Rapid Test shows a clinical accuracy of 99.50%.
ABOUT ALPHA PHARMA
ALPHA PHARMA is one of the leading bio-technology companies in the EU, best known for the production and distribution of blood analysis systems, most commonly used in the detection and monitoring of diabetes.
Headquartered in Bitonto in the South West of Italy, Alpha Pharma develops leading predictive and precision medicine and technology. Products include the latest-generation, blood glucose meters and glycated haemoglobin and lipid profile analysers, which are distributed across the globe. Millions of people have benefited from Alpha Pharma’s diagnostic technology.
In February, as Italy became the first European country to truly experience the devasting effects of the coronavirus, Alpha Pharma focused its expertise and resources, pivoting its technology to the development of covid-19 testing.
Recommended for use by a healthcare professional, Alpha Pharma’s tests deliver accuracy, information and can significantly help to prevent the spread of covid-19 by diagnosing both symptomatic and asymptomatic people.
Alpha PH secured the UK and Ireland distribution rights from Alpha Pharma to bring its covid-19 testing products to the market and the NI company is now distributing three products, the IRIS SARS-CoV-2 Ag Saliva Rapid Test, the VivaDiag SARS-CoV-2Ag rapid swab antigen test and the IRIS VivaDiag COVID-19 IgM IgG rapid antibody test.
Alpha Pharma’s tests have been developed with safety and accuracy as paramount. Each test has undergone rigorous testing. The IRIS SARS-CoV-2 Ag Saliva Rapid Test, VivaDiag SARS-CoV-2Ag rapid test (antibodies test) and IRIS VivaDiag COVID-19 IgM IgG rapid test (swab test) are manufactured in compliance with CE and WHO directives.
- Manufactured in compliance with CE directives
- Manufactured in compliance with WHO directives
- Registered with Italian Ministry of Health
- EUA (emergency use authorisation) granted by US Food & Drug Administration